Prediction of amyloidosis from neuropsychological and MRI data for cost effective inclusion of pre-symptomatic subjects in clinical trials - Archive ouverte HAL Access content directly
Conference Papers Year :

Prediction of amyloidosis from neuropsychological and MRI data for cost effective inclusion of pre-symptomatic subjects in clinical trials

(1) , (1, 2, 3) , (1, 2, 3) , (1, 2, 3, 4) , (1, 4) , (1, 2, 3) , (1, 2, 3, 5) , (6)
1
2
3
4
5
6

Abstract

We propose a method for selecting pre-symptomatic subjects likely to have amyloid plaques in the brain, based on the automatic analysis of neuropsychological and MRI data and using a cross-validated binary classifier. By avoiding systematic PET scan for selecting subjects, it reduces the cost of forming cohorts of subjects with amyloid plaques for clinical trials, by scanning fewer subjects but increasing the number of recruitments. We validate our method on three cohorts of subjects at different disease stages, and compare the performance of six classifiers, showing that the random forest yields good results more consistently, and that the method generalizes well when tested on an unseen data set.
Fichier principal
Vignette du fichier
Ansart_et_al.pdf (378.8 Ko) Télécharger le fichier
Origin : Files produced by the author(s)
Loading...

Dates and versions

hal-01578422 , version 1 (29-08-2017)

Identifiers

  • HAL Id : hal-01578422 , version 1

Cite

Manon Ansart, Stéphane Epelbaum, Geoffroy Gagliardi, Olivier Colliot, Didier Dormont, et al.. Prediction of amyloidosis from neuropsychological and MRI data for cost effective inclusion of pre-symptomatic subjects in clinical trials. Multimodal Learning for Clinical Decision Support, Sep 2017, Quebec City, Canada. ⟨hal-01578422⟩
331 View
346 Download

Share

Gmail Facebook Twitter LinkedIn More